Archive - March 2021
CureVac signs manufacturing agreement with Novartis for COVID-19 vaccine candidate
Pfizer’s ALK inhibitor Lorbrena scores expanded FDA approval for first-line NSCLC
MHRA to fast-track vaccines modified for new COVID-19 variants
EMA begins rolling review process for Sputnik V COVID-19 vaccine
ConserV Bio partners with eTheRNA on mRNA vaccine development
NICE rejects rare blood cancer treatment Poteligeo in final appraisal
EMA launches rolling review of Russia’s Sputnik V COVID-19 vaccine
Chancellor pledges an extra £1.65bn for UK’s COVID-19 vaccination roll-out